COMMUNIQUÉS West-GlobeNewswire

Sonus Microsystems and Medtronic Partner to Advance AI-Powered Maternal Health Monitoring
15/09/2026
Partnership will pair Medtronic vital-sign monitoring with Sonus’s ultrasound AI platform in field studies, funded by the Gates Foundation VANCOUVER, British Columbia and LAFAYETTE, Colo., Sept. 15, 2026 (GLOBE NEWSWIRE [...]
New Data Reveal Rapid, Sustained Quality-of-Life Improvements for Eczema and Psoriasis Patients Using Zest Health's Virtual Dermatology Platform
15/09/2026
Findings published in Dermatology Practical & Conceptual show a 65.5% reduction in disease-related quality-of-life impact and a more than 4x drop in severe cases by patients' final visit WASHINGTON, Sept. 15, 2026 ( [...]
Er-Kim Announces Positive Reimbursement Decision in the Czech Republic for Vafseo® (vadadustat) to Treat Symptomatic Anaemia in Adult CKD Dialysis Patients
15/09/2026
State Institute for Drug Control (SÚKL) has officially evaluated and approved the drug’s price and coverage under the public health insurance system WARSAW, Poland, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Er-Kim , an [...]
Shriners Hospitals for Children Canada Achieves a National First in Pediatric Motion Analysis
15/09/2026
Home to Canada's only Motion Analysis Centre accredited by the Commission for Motion Laboratory Accreditation (CMLA) MONTREAL, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Shriners Hospitals for Children Canada (SHCC) today [...]
Les Hôpitaux Shriners pour enfants Canada réalisent une première nationale en analyse du mouvement pédiatrique
15/09/2026
Seul centre d’analyse du mouvement au Canada agréé par la Commission for Motion Laboratory Accreditation (CMLA) MONTRÉAL, 15 sept. 2026 (GLOBE NEWSWIRE) -- Les Hôpitaux Shriners pour enfants Canada annoncent aujourd’hui [...]
Reflect Scientific Announces Liquid Nitrogen Cooling Technology for AI Data Center Applications
15/09/2026
OREM, Utah, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), today announced that its proprietary liquid nitrogen temperature control technology is available for application in the rapidly [...]
Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
15/09/2026
Ingrid Zhang, an accomplished global biopharmaceutical leader, joins Legend Biotech following a comprehensive Board-led search process BRIDGEWATER, N.J., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation ( [...]
Egle Therapeutics to Present Clinical Data at the Upcoming European Academy of Dermatology and Venereology (EADV) Congress in Vienna
15/09/2026
Egle to share clinical data on EGL-003, the company's most advanced Treg-selective IL-2 agonist for atopic dermatitis PARIS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Egle Therapeutics (“Egle”), a clinical-stage biotechnology [...]
Orvida Pharma Announces Interim Financing Led by Recordati to Advance Ontivatrep Development for Rare Genetic Skin Diseases
15/09/2026
Proceeds to support continued clinical development of ontivatrep, an oral TRPV3 inhibitor, with Phase 1b topline results in Olmsted syndrome expected by the end of 2026 NESS ZIONA, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE [...]
BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
15/09/2026
Statistically significant benefits observed in bezisterim-treated Long COVID patients in pre-specified subgroups with high baseline fatigue, cognitive impairment, and/or post‑exertional malaise Bezisterim showed a [...]
Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026
15/09/2026
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”), a commercial-stage international biopharmaceutical company focused on cannabinoid-based medicines, is pleased to announce that [...]
Ontario Healthcare Stakeholders Unite on Shared Action Plan to Reduce Tobacco and Nicotine Dependence
15/09/2026
Vanguard healthcare, policy, and community stakeholders consolidate as newly formed Ontario Nicotine Action Table (ONAT) to build long-term plan for coordinated action TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- A broad [...]
Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab
15/09/2026
Strategic CDMO collaboration strengthens Axiom’s development infrastructure as the company prepares to advance its therapeutic pipeline. SAN DIEGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Axiom Biosciences , a clinical-stage [...]
PolarityBio Announces FDA Acceptance for Filing of SkinTE® BLA with Priority Review in Diabetic Foot Ulcers
15/09/2026
● PDUFA Target Action Date Set for March 16, 2027 SALT LAKE CITY, Sept. 15, 2026 (GLOBE NEWSWIRE) -- PolarityBio ® , a late-stage biotechnology company addressing unmet needs in wound healing through innovation in [...]
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™
15/09/2026
Milestone continues the progress towards detection of all 20 amino acids by end of 2026 BRANFORD, Conn., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a [...]
Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS
15/09/2026
Enrollment advances into Cohort 2 of Phase 1 trial of RPT1G in relapsed/refractory acute myeloid leukemia (AML) and higher-risk myelodysplastic syndromes (MDS) U.S. Food and Drug Administration accepts Investigational [...]
BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer
15/09/2026
45% objective response rate and 88% disease control rate observed in patients with EGFR C797S-positive resistance to prior EGFR inhibitors, with or without concurrent T790M, a difficult-to-treat population with no [...]
Satellos to Present at the 31st Annual Congress of the World Muscle Society
15/09/2026
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today [...]
Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026
15/09/2026
Prostate cancer and Alzheimer’s disease imaging programs position the Company for FDA submissions in 2027 across two of the fastest-growing segments in molecular imaging BEDMINSTER, N.J., Sept. 15, 2026 (GLOBE NEWSWIRE [...]

Pages